IP Library › Granted Patent US 11,678,659
Granted Patent B2
US 11,678,659 · App. 15/317,716 · Granted Jun 20, 2023

Use as rodenticides of compounds that inhibit blood coagulation

Inventor: Dietrich Gulba (Essen, DE)
A01N25/004A01N41/06A01N43/40A01N43/44A01N43/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,678,659
App. No.
15/317,716
Granted
Jun 20, 2023
Kind
B2
Abstract

The invention relates to a use, a method and a poison in which a thrombin inhibitor, a thrombin receptor antagonist, a factor Xa inhibitor, a PAI (plasminogen activator inhibitor), a P2Y12 ADP receptor antagonist or a GPIIb/IIIa receptor antagonist are used as rodenticide.

Claims (29)

1. A method of combatting a rodent, the method comprising administering to the rodent a rodenticide comprising at least a factor Xa inhibitor and an antagonist of the ADP receptor P2Y12,

wherein the inhibitor of factor Xa is a compound of the following formula or a salt or hydrate thereof tolerable for a rodent:

wherein Q 3 is:

R 59 is H, F, CI or Br, R 60 , R 61 , R 62 and R 63 are each independently H, F, Cl, Br, Me, NO 2 , OH, OMe, NH 2 , NHAc, NHSO 2 Me, CH 2 OH and CH 2 NH 2 and R 64 is F, Cl, Br, Me, OH or OMe; and

wherein the antagonist of the ADP receptor P2Y12 is:

i) a compound of the following formula or a salt or a hydrate thereof tolerable for a rodent:

wherein R 94 is H, a halogen, hydroxy or C 1-6 alkyl, R 95 is H, a halogen, hydroxy, nitro, C 1-6 alkyl or C 1-6 alkoxy and R 96 is H or a halogen;

ii) a compound of the following formula or a salt or a hydrate thereof tolerable for a rodent:

wherein Y 1 is —OR 98 or —N(R 99 )R 100 , wherein R 99 and R 100 are each independently H, a halogen or a C 1-4 alkyl group and R 98 is H or C 1-4 alkyl and R 97 is H, a halogen or C 1-4 alkyl group; or

iii) a compound of the following formula or a salt or a hydrate thereof tolerable for a rodent:

wherein R 101 is H, OH, amino, C 1 to C 4 alkoxy, Aryl-C 1-4 -alkyloxy, C 1-18 alkanoyloxy, C 3-6 alkenoyloxy or arylcarbonyloxy, R 102 is C 1-10 alkanoyl, C 3-6 alkenoyl, C 4-8 cycloalkylcarbonyl including 3 to 7 ring atoms, substituted benzoyl or 5,6-dihydro-1,4,2-dioxazine-3-yl, Y 2 is NH, O or S, R 103 is H, a halogen, OH, amino, C 1-4 alkyl, C 1-4 alkoxy, C 1-4 alkylthio or a carboxy group.

2. The method according to claim 1 , wherein the inhibitor of factor Xa comprises betrixaban and the antagonist of the ADP receptor P2Y12 comprises prasugrel.

3. The method according to claim 2 , wherein the rodenticide is administered as a series of doses.

4. The method according to claim 3 , wherein each dose does not result in acute toxicity to the rodent.

5. The method according to claim 3 , wherein each dose is nonlethal to humans.

6. The method according to claim 2 , wherein each dose of the rodenticide is provided in a food bait.

7. A harmful rodent bait comprising at least a rodenticidally effective amount of a factor Xa inhibitor and a rodenticidally effective amount of an antagonist of the ADP receptor P2Y12, wherein the inhibitor of factor Xa is a compound of the following formula or a salt or hydrate thereof tolerable for a rodent:

wherein Q 3 is:

R 59 is H, F, CI or Br, R 60 , R 61 , R 62 and R 63 are each independently H, F, Cl, Br, Me, NO 2 , OH, OMe, NH 2 , NHAc, NHSO 2 Me, CH 2 OH and CH 2 NH 2 and R 64 is F, Cl, Br, Me, OH or OMe; and

wherein the antagonist of the ADP receptor P2Y12 is:

i) a compound of the following formula or a salt or a hydrate thereof tolerable for a rodent:

wherein R 94 is H, a halogen, hydroxy or C 1-6 alkyl, R 95 is H, a halogen, hydroxy, nitro, C 1-6 alkyl or C 1-6 alkoxy and R 96 is H or a halogen;

ii) a compound of the following formula or a salt or a hydrate thereof tolerable for a rodent:

wherein Y 1 is —OR 98 or —N(R 99 )R 100 , wherein R 99 and R 100 are each independently H, a halogen or a C 1-4 alkyl group and R 98 is H or C 1-4 alkyl and R 97 is H, a halogen or C 1-4 alkyl group; or

iii) a compound of the following formula or a salt or a hydrate thereof tolerable for a rodent:

wherein R 101 is H, OH, amino, C 1 to C 4 alkoxy, Aryl-C 1-4 -alkyloxy, C 1-18 alkanoyloxy, C 3-6 alkenoyloxy or arylcarbonyloxy, R 102 is C 1-10 alkanoyl, C 3-6 alkenoyl, C 4-8 cycloalkylcarbonyl including 3 to 7 ring atoms, substituted benzoyl or 5,6-dihydro-1,4,2-dioxazine-3-yl, Y 2 is NH, O or S, R 103 is H, a halogen, OH, amino, C 1-4 alkyl, C 1-4 alkoxy, C 1-4 alkylthio or a carboxy group.

8. The harmful rodent bait according to claim 7 , wherein the inhibitor of factor Xa comprises betrixaban and the antagonist of the ADP receptor P2Y12 comprises prasugrel.

9. The harmful rodent bait according to claim 8 , further comprising a rodent food, the rodent food comprising the betrixaban and the prasugrel.

10. The harmful rodent bait according to claim 8 , wherein the rodent bait comprises a combined concentration of the betrixaban and the prasugrel that is nonlethal to humans when ingested.

Priority Claims (1)
DE 10 2014 108 210.9 · Jun 11, 2014 · national
Continuity (1)
Related Publication 20170127667A1 · May 11, 2017